Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28012770.
- Also identified by DOI 10.1016/j.juro.2016.10.101.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.
Medical subject headings
- Antineoplastic Agents, Immunological
- BCG Vaccine
- Carcinoma, Transitional Cell
- Neoplasm Recurrence, Local
- Urinary Bladder Neoplasms